PHOENIX -- Selected stroke patients did not benefit clinically from having the window of tenecteplase therapy extended beyond the first few hours of stroke onset, the randomized TIMELESS trial found.

Please provide your email address to receive an email when new articles are posted on . The RapidAI software successfully processed and identified more eligible large vessel occlusion cases vs. VizAI.

Examples of patients with large vessel occlusions correctly predicted by the deep-learning model. Top row: CT angiography slices; middle row: maximal intensity projection images; bottom row: heatmaps ...

The US Food and Drug Administration (FDA) has granted clearance to the Rapid LVO automated software, which is designed to detect suspected large-vessel occlusions (LVOs). The software may aid the ...

United Launch Alliance (ULA) path to the USSF-7 launch achieved a major milestone on Thursday during “Launch Vehicle on Stand (LVOS)” operations. This marks the beginning of the final assembly of the ...

The AI system can identify suspected posterior and anterior large and medium vessel occlusions, aneurysms, and hemorrhages, potentially revolutionizing neurovascular care. Aidoc, a leading Israeli ...

Children are less likely than adults to have acute strokes caused by large-vessel occlusions (LVOs), but when they do, endovascular therapy to remove the blockage may be a good option, a small ...

MENLO PARK, Calif.--(BUSINESS WIRE)--RapidAI, the worldwide leader in advanced imaging for stroke, today announced that Rapid LVO has received Food and Drug Administration (FDA) clearance for ...

Bringing stroke patients straight to the angiography suite of a hospital capable of endovascular therapy reduced hospital delays and improved care for people with suspected large vessel occlusions ...

How best to deliver endovascular therapy—a proven treatment for acute ischemic strokes caused by large-vessel occlusions (LVOs)—to populations outside of urban areas remains a tricky question, and ...